DEC 14, 2020 8:11 AM PST

Fibronectin Could Act as a Biomarker for Early Prognosis of Live Cancer

WRITTEN BY: Jasper Cantrell

Diagnostics is one of the key pillars of modern medicine. Diagnostics allows patients and doctors to identify a problem and even get ahead of it if caught early enough.


Cancer diagnostics is an example of how diagnostics can effect significant change. Many cancers can escape notice for months or years, and recurrence is unfortunately quite common. Current research is trying to develop diagnostic tools that can catch cancers at earlier stages, both before and after treatment. Statistically, patients have a much better chance of defeating cancer if it is caught early.

Hepatocellular carcinoma, or liver cancer, is a common form of cancer across the world. It also has a high chance of recurrence after treatment, even when caught early. Current diagnostic testing relies on either imaging, biopsies, or biomarker tracking. The current standard biomarker is α-fetoprotein (AFP), but it lacks efficacy in detecting early-stage liver cancer.

In a new study out of Seoul National University in South Korea, a team of scientists wanted to see how the protein fibronectin would perform as a prognostic biomarker. Fibronectin is known to be expressed at high levels in some cancers and promote tumor progression. The team wanted to know if fibronectin to predict recurrence in a small group of liver cancer patients who experienced remission after successful treatment.

The team analyzed blood levels of both fibronectin and the current standard AFP and other characteristics such as age, sex, etc. All of the 83 patients in the study had early-stage liver cancer that had been successfully treated into remission. Of these, 39 patients developed recurrence over four years. Looking at the biomarker levels, the old standard, AFP, was of no significant predictive value. On the other hand, patients who developed recurrence tended to have higher fibronectin levels post-treatment. The team combined this with the observation that men were also more likely to have a recurrence and developed a prognostic test that could predict recurrence with better results than AFP.

This study managed to develop a simple and easy-to-use test that could predict early-stage liver cancer recurrence after successful remission better than AFP biomarker tests. The prognostic test used fibronectin levels and a patient’s sex, which performed better than alone. The study focused on early-stage liver cancers, and therefore the team admits the test may not work well with later-stage cancers. Catching cancer early is the goal, so even if this doesn’t hold up to late-stage cancers, it is a great step in the right direction.

The study concludes, “changes in serum fibronectin levels may be a surrogate indicator for assessment of treatment response in HCC. Our biomarker-based nomogram might be helpful for predicting tumor recurrence in patients with early HCC undergoing curative treatment.”

Sources: Nature Scientific Reports, Research Square

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 08, 2021
Immunology
Fueling the Immune System's Killers
JUN 08, 2021
Fueling the Immune System's Killers
There’s a group of “killers” protecting your body against infections and eliminating potentially cance ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 17, 2021
Clinical & Molecular DX
Delays in Breast Cancer Diagnoses Among Black Women
AUG 17, 2021
Delays in Breast Cancer Diagnoses Among Black Women
Thanks to breakthrough diagnostic technologies, we can now catch the early warning signs of breast cancer much faster th ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
OCT 21, 2021
Cancer
Exercise: A Secret Weapon to Combat Prostate Cancer?
OCT 21, 2021
Exercise: A Secret Weapon to Combat Prostate Cancer?
Exercise oncology is an evolving science that considers the addition of physical activity regimens to the treatment ...
Loading Comments...